广州必贝特医药股份有限公司关于开立募集资金现金管理专用结算账户的公告

Core Viewpoint - The company has approved the use of up to RMB 900 million of temporarily idle raised funds for cash management, aiming to enhance fund efficiency while ensuring the safety of the raised funds [1][5]. Group 1: Establishment of Special Settlement Accounts - The company has opened special settlement accounts for cash management at CITIC Securities and Guotai Junan Securities to manage the raised funds [2]. - These accounts will be used exclusively for the settlement of cash management products and will not hold non-raised funds or serve other purposes [2]. Group 2: Risk Control Measures - The company will adhere to relevant regulations and establish a robust approval and execution process for cash management to ensure fund safety [3]. - Investment targets will be selected based on their credibility and ability to safeguard funds, following a prudent investment principle [3]. - The finance department will monitor cash management products and take necessary measures to mitigate risks affecting fund safety [3]. - Independent directors and the audit committee will supervise fund usage and may engage professional institutions for audits if necessary [3]. Group 3: Impact on the Company - The cash management of temporarily idle raised funds will be conducted without affecting the implementation of investment projects or the normal operation of the company [4]. - This initiative is expected to improve the efficiency of fund usage and enhance overall performance, ultimately benefiting shareholders [4][5].